Table 1.
References | Study design | Number of patients | Technical success rate (%) | Clinical success rate (%) | Adverse event rate (%) | Reintervention rate (%) |
---|---|---|---|---|---|---|
Artifon et al.[16] | Prospective, RCT | EUS-BD: 13 PTBD: 12 |
13/13 (100) 12/12 (100) |
13/13 (100) 12/12 (100) |
2/13 (15) 3/12 (25) |
- |
Bapaye et al.[17] | Retrospective | EUS-BD: 25 PTBD: 26 |
23/25 (92) 26/26 (100) |
- | 5/25 (20) 12/26 (46) |
- |
Khashab et al.[18] | Retrospective | EUS-BD: 22 PTBD: 51 |
19/22 (86) 51/51 (100) |
19/19 (100) 47/51 (92) |
4/22 (18) 20/51 (39) |
3/19 (16) 23/51 (45) |
Bill et al.[19] | Retrospective | EUS-BD: 25 PTBD: 25 |
19/25 (76) 25/25 (100) |
24/25 (96) 20/25 (80) |
7/25 (28) 9/25 (36) |
4/25 (16) 15/25 (60) |
Giovannini et al.[20] | Prospective, RCT | EUS-BD: 20 PTBD: 21 |
19/20 (95) 17/21 (85) |
- | 7/20 (35) 12/21 (60) |
- |
Sharaiha et al.[21] | Retrospective | EUS-BD: 47 PTBD: 13 |
43/47 (92) 11/13 (93) |
27/43 (63) 3/11 (27) |
5/47 (15) 11/13 (85) |
12/43 (28) 10/11 (91) |
Torres-Ruiz et al.[22] | Retrospective | EUS-BD: 35 PTBD: 31 |
28/35 (81) 28/31 (90) |
25/28 (89) 19/28 (68) |
9/35 (26) 20/31 (65) |
2/28 (7) 8/28 (29) |
Sportes et al.[23] | Retrospective | EUS-BD: 31 PTBD: 20 |
31/31 (100) 20/20 (100) |
25/31 (86) 15/20 (83) |
5/31 (16) 2/20 (10) |
2/31 (6) 4/21 (19) |
Lee et al.[24] | Prospective, RCT | EUS-BD: 34 PTBD: 32 |
32/34 (94) 31/32 (97) |
28/32 (88) 27/31 (87) |
3/34 (9) 9/32 (28) |
11/32 (34) 29/31 (94) |
Ogura et al.[25] | Retrospective | EUS-BD: 30 PTBD: 18 |
29/30 (97) 16/18 (89) |
26/29 (90) 14/16 (88) |
3/30 (10) 3/18 (17) |
- |
RCT: Randomized controlled trial, EUS-BD: EUS-guided biliary drainage, PTBD: Percutaneous transhepatic biliary drainage